|
|
DYD B-11
|
|
 |
hpmuaeqOsU |
 |
388 |
|
 |
| Which team do you support? http://boobs.pet boobs pressing "We believe this introduces new clinical, regulatory andcommercial risk for this competitive drug, which should benefitSarepta given the more favorable therapeutic index thateteplirsen appears to have," Skorney said. |
|
 |
Tommy |
 |
2019-05-31 22:39:05 |
|
|
|
|
|
|
|
|
|
